0001209191-22-029596.txt : 20220517
0001209191-22-029596.hdr.sgml : 20220517
20220517161554
ACCESSION NUMBER: 0001209191-22-029596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220517
DATE AS OF CHANGE: 20220517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Couling John D
CENTRAL INDEX KEY: 0001894052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 22934701
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-16
0
0001308547
Dolby Laboratories, Inc.
DLB
0001894052
Couling John D
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
0
1
0
0
SVP, Entertainment
Class A Common Stock
2022-05-16
4
S
0
185
74.63
D
79235
D
Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest.
Shares include 248 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022.
/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
2022-05-17